erika hamilton, md, considers the comparison between the monarche and pallas clinical trials

Published 3 years ago • 51 plays • Length 1:37

Download video MP4
Download video MP3

Similar videos

1:13

erika hamilton, md, considers the significance of the monarche study & the use of abemaciclib
1:38

erika hamilton, md, considers the role of ngs testing for breast cancer patients
1:46

erika hamilton, md, regarding the phase iii monarche trial presented at esmo 2020
1:08

erika hamilton, md, discusses findings from the mario-3 clinical trial presented at the 2020 sabcs
2:21

erika hamilton, md, regarding the use of cdk 4/6 inhibitors in clinical practice
1:16

erika hamilton, md, on the standard of care for high-risk early hr , her2- breast cancer
1:40

erika hamilton, md, on promising treatment options in the management of her2 advanced breast cancer
4:14

sara hurvitz, md, discusses the recently announced results of monarch e and pallas adjuvant trials
19:55

left-right difference in breast cancer inspires new research | ann ramsdell | tedxcolumbiasc
4:19

monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
2:09

women widely underrepresented in medical research studies
1:13

erika hamilton, md, shares thoughts on tolerability in high risk early breast cancer patients
3:18

updated standardized definitions for efficacy end points in adjuvant breast cancer clinical trials
2:43

adjuvant palbociclib strikes out in pallas trial | erica mayer
1:06

priya rastogi, md, considers the interchangeability of cdk 4/6 inhibitors
5:06

safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
3:13

ac versus taxac in high-risk her2-negative mbc
2:21

palbociclib with adjuvant endocrine therapy in early breast cancer - pallas study
2:30

clinical trials in breast cancer: pallas, monarch 3 and solar-1
1:38

calgb 49907 trial: standard chemotherapy versus capecitabine for older women with breast cancer
3:30

final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
0:45

dr. hamilton on using pcr to classify risk in her2 breast cancer

Clip.africa.com - Privacy-policy